BURLINGTON, Mass.–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will present and host investor meetings at the 17th Annual Midwest IDEAS Conference on Wednesday, August 26, 2026.
The Company presentation is scheduled to begin at 9:55 a.m. CT / 10:55 a.m. ET. The presentation is webcast and can be accessed through the conference host’s main website: https://www.threepartadvisors.com/midwest and in the investor relations section of the company website at: www.908devices.com.
About 908 Devices
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.
Contacts
IR & Media
Barbara Russo
[email protected]
